Investigation of the Efficacy and Safety of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma

Background/Aim: Nivolumab, an anti-PD-1 inhibitor, has demonstrated efficacy in patients with several types of recurrent and metastatic (R/M) squamous cell carcinoma of the head and neck. We evaluated patients with R/M-NPC receiving nivolumab. Patients and Methods: Twelve patients with R/M-NPC were...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:In Vivo
Hauptverfasser: SATO, HIROKI, FUSHIMI, CHIHIRO, OKADA, TAKURO, MATSUKI, TAKASHI, KONDO, TAKAHITO, OMURA, GO, MIURA, KOUKI, YAMASHITA, TAKU, OKAMOTO, ISAKU, TSUKAHARA, KIYOAKI
Format: Artigo
Sprache:Inglês
Veröffentlicht: International Institute of Anticancer Research 2020
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7652473/
https://ncbi.nlm.nih.gov/pubmed/32871839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12127
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge